Nivolumab in Combination With Chemoradiation for Patients With Stage II-IVB Nasopharyngeal Carcinoma, A Phase II Study With Correlative Biomarkers
Phase of Trial: Phase II
Latest Information Update: 28 May 2018
At a glance
- Drugs Cisplatin (Primary) ; Nivolumab (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 19 Jan 2018 Status changed from not yet recruiting to recruiting.
- 30 Oct 2017 Planned initiation date changed from 15 Oct 2017 to 1 Dec 2017.
- 01 Sep 2017 New trial record